Robert Molokie is an Oncology physician affiliated with Illinois College. OpenAlex indexes 273 publications with 4,311 citations (h-index 35); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1740 W Taylor St
Chicago, IL 606127232
Telephone
866-600-2273Registry record last updated 12 Jun 2009.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tempus AI, IncProgram year20252 payments
- Tempus AI, IncProgram year20243 payments
- INTUITIVE SURGICAL, INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
61.4%Opioid Agonist48.8%Morphine Sulfate31%Morphine Sulfate Er27%Hydromorphone Hcl25%Oxycodone Hcl10%Fentanyl4%Methadone Hcl4%Part D<11 patientsTricyclic Antidepressant2.5%Amitriptyline Hcl100%Part D<11 patients+ 6 more classes in this area
Respiratory
24.5%Opioid Agonist20.5%Hydrocodone-Acetaminophen100%Part D≥30 patientsbeta2-Adrenergic Agonist2.6%Albuterol Sulfate Hfa100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
6.5%Antimetabolite6.5%Hydroxyurea100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2011–2025 per NIH RePORTER. The latest:
- Exploring the Mediterranean Diet as A Promising Approach for Alleviating Chronic Pain in Sickle Cell Disease
University of Illinois at Chicago
FY2025$437,458R21AT013292 - Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
University of Illinois at Chicago
FY2024$1,584,065UH3AT011265 - Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
University of Illinois at Chicago
FY2023$1,582,439UH3AT011265
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Stepped-Wedge Randomized Controlled Trial: Effects of eHealth Interventions for Pain Control Among Adults With Cancer in Hospice
Journal of Pain and Symptom Management
2019 - Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease
Biology of Blood and Marrow Transplantation
2018
Similar KOLs
Other experts from the same institution or the same specialty.
John Daugirdas, MD
Illinois College
Lewis Hsu, MD, PhD
Illinois College
Konstantin Slavin, MD
Illinois College
Ana Ricardo, MD, MPH
Illinois College
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”